Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation: A follow-up report of the French protocol LALA 87

Hematology/Oncology Clinics of North America

Volumn 14, Issue 6, 2000, Pages 1353-1366

  Thiebaut, Anne ^a   Vernant, Jean Paul ^b   Degos, Laurent ^c   Huguet, Franoise Rigal ^d   Reiffers, Josy ^e   Sebban, Catherine ^a   Lepage, Eric ^f   Thomas, Xavier ^a   Fire, Denis ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d CHU PURPAN   (France)

^e HAUT LÉVÊQUE HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; MAFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; ZORUBICIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SIDE EFFECT; SURVIVAL RATE;

EID: 0033636586     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70190-8     Document Type: Review

References (39)

1. Bone marrow transplantation for acute lymphoblastic leukemia
2. Allogeneic or autologous bone marrow transplantati on for acute lymphoblastic leukemia in first remission
3. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission
4. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA 87)
5. The biology and treatment of acute lymphoblastic leukemia in adults
6. Role of allogeneic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma in first complete remission
7. Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukemia in adults, Report from the Medical Research Council Working Party on Adult Leukemia
8. Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults
9. Treatment of adult acute lymphoblastic leukemia. Preliminary results and a trial from the French group
10. Comparison of chemotherapy, autologous and allogeneic bone marrow transplantation in first remission of adult acute lymphoblastic leukemia, a preliminary analysis
11. Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as post remission therapy
12. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission
13. A course-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia
14. GIMEMA ALL 0183: A multicentric study on adult acute lymphoblastic leukaemia in Italy
15. Autologous bone marrow transplantation (ABMT) for acute leukemia in remission. 5th European survey evidence in favor of marrow purging. Influence of retransplant intervals
16. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique
17. Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults
18. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
19. Acute lymphoblastic leukemia: Progress in children, less in adults
20. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission
21. Results of treatment with hyper CVAD, a dose intensive regimen, in adult acute lymphoblastic leukemia
22. Non parametric estimation from incomplete observations
23. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia
24. Treatment of adult acute lymphoblastic leukemia
25. A five drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811
26. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy. A follow up report
27. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto ALL 0288: A multicentric study on adult acute lymphoblastic leukaemia: Preliminary results
28. The GIMEMA ALL 0183 trial: Analysis of 10 years follow up
29. Chemotherapy vs HLA identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission
30. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
31. Curing children of leukemia
32. Acute lymphoblastic leukemia
33. Autologous bone marrow transplant
34. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: A comparative study
35. Therapy of adult ALL. Overview, of 2 successive EORTC studies (ALL 2 and ALL 3)
36. Marrow transplantation for patients with acute lymphoblastic leukemia in remission
37. Estimated 6 years event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
38. Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission
39. Cytarabine with high dose mitoxantrone induces rapid complete remission in adult acute lymphoblastic leukemia without the use of vincristine or prednisone